1 We recently described that several 2-(2,5-dimethoxy-4-substituted phenyl)ethylamines (PEAs), including 4-I ¼ 2C-I, 4-Br ¼ 2C-B, and 4-CH 3 ¼ 2C-D analogs, are partial agonists at 5-HT 2C receptors, and show low or even negligible intrinsic efficacy at 5-HT 2A receptors. These results raised the proposal that these drugs may act as 5-HT 2 antagonists. 2 To test this hypothesis, Xenopus laevis oocytes were microinjected with the rat clones for 5-HT 2A or 5-HT 2C receptors. The above-mentioned PEAs and its 4-H analog (2C-H) blocked the 5-HT-induced currents at 5-HT 2A , but not at the 5-HT 2C receptor, revealing 5-HT 2 receptor subtype selectivity. The 5-HT 2A receptor antagonism required a 2-min preincubation to attain maximum inhibition. 3 All PEAs tested shifted the 5-HT concentration-response curves to the right and downward. Their potencies varied with the nature of the C(4) substituent; the relative rank order of their 5-HT 2A receptor antagonist potency was 2C-I42C-B42C-D42C-H.
Introduction
There is abundant evidence in support of the notion that psychostimulants of the indolylalkylamine and phenylethylamine families require the activation of central 5-HT 2 receptors (Nichols, 1997) . Although radioligand displacement experiments show a reasonable correlation between 5-HT 2 receptor affinities in rat brain membranes or cultured cells expressing cloned human 5-HT 2 receptors and the human 'hallucinogenic' potency of many phenylisopropylamines (PIAs, (7)-1-(2,5-dimethoxy-4-substituted phenyl)-2-propylamines), these compounds are not generally subtype selective Nelson et al., 1999) . There is a body of evidence, derived from electrophysiological and behavioral assays, that implicates 5-HT 2A receptors as a main CNS target for these hallucinogenic and psychotropic drugs (Mckenna & Peroutka, 1989; Pierce & Peroutka, 1989; Krebs-Thomson et al., 1998; Aghajanian & Marek, 1999) . 2C-B (2-(4-bromo-2,5-dimethoxyphenyl)-ethylamine) is a popular and recreational psychostimulant phenylethylamine (PEA), known among other street names as 'nexus' or 'cyber'. Several related drugs, as [(7)-1-(4-bromo-2,5-dimethoxyphenyl)-2-propylamine] (DOB), with varying substituents at C(4), have similar psychotropic activity probably due to the activation of a common mechanism (Shulgin & Shulgin, 1991; Giroud et al., 1998; de Boer et al., 1999) . DOB, a known 5-HT 2A/2C agonist, was used as evidence to infer that the corresponding PEA analog 2C-B might also exert its psychotropic actions through the activation of 5-HT 2A/2C receptors, either as a full or partial agonist, a feature common to other psychoactive drugs.
Recently, Xenopus laevis oocytes microinjected with clones of the rat 5-HT 2A or the 5-HT 2C receptors were used to characterize the pharmacology of PIAs and their corresponding PEA pairs (Table 1 and Acun˜a-Castillo et al., 2002) .
Although this new experimental model has limitations, in part due to the transient expression of the transfected proteins and likely also to differential engagement of G proteins, the Acun˜a-Castillo et al. (2002) study demonstrated that the PIAs are generally full 5-HT 2C receptor agonists and partial agonists at the 5-HT 2A receptor, a finding in accordance with the current literature on the mode of action of these drugs. Furthermore, they reported in the same study that the similarly substituted PEAs are less efficacious agonists, some of them with low or negligible efficacy at the 5-HT 2A receptor subtype. Based on the report of Acun˜a-Castillo et al. (2002) , we now suggest that PEAs with null or negligible intrinsic activity might behave as 5-HT 2A receptor antagonist in X. laevis oocytes. To test our working hypothesis, 5-HT 2A and 5-HT 2C receptors were expressed in Xenopus oocytes and evaluated the interaction of a series of PEAs with these receptors. These findings show new evidence in support of the proposal that the hallucinogenic effect of PEAs is not directly related to 5-HT 2A agonism, but it might be possibly associated with mechanism(s) or receptor(s) other than the classical partial agonism at the 5-HT 2A receptor. This novel concept may enlighten and help to understand the mode of action of PEAs and related psychoactive compounds.
Methods
Oocyte harvesting, microinjection of rat 5-HT 2A and 5-HT 2C receptor clones, and characterization of 5-HT-induced currents X. laevis ovary lobes were surgically removed; stage V and VI oocytes were manually defolliculated and further treated with collagenase II as previously described (Acun˜a-Castillo et al., 2002) . Oocytes were then microinjected intracytoplasmatically with 10-20 ng of a cRNA for the rat 5-HT 2A or 5-HT 2C receptor clones. The oocytes were incubated for 36-48 h at 151C in standard Barth's solution supplemented with 10 UI/l penicillin-streptomycin, 0.5 mM theophylline and 2 mM pyruvate.
To assess the expression of the 5-HT receptors, oocytes were impaled with two electrodes in a voltage-clamp configuration using an OC-725C oocyte clamp (Warner Instrument Corp.), as detailed previously by Acun˜a-Castillo et al. (2002) ; the membrane potential was fixed at À70 mV. To test the expression of the receptors following transfection, the oocytes were perfused for 10-s with a test concentration of either 100 nM 5-HT in the case of the 5-HT 2A or 10 nM 5-HT for the 5-HT 2C receptor, values that were previously determined to be close to the EC 50 for each receptor. These test challenges were applied regularly every 15-20 min, to avoid desensitization of the 5-HT-evoked currents. When an oocyte yielded a significant current, the same concentration of 5-HT was applied several times until a stable response was attained. 5-HT and related analogs were dissolved in perfusion buffer and superfused at a constant flow rate of 2 ml/min. Uninjected oocytes did not respond to 5-HT or to any PEAs tested. A minimum of four oocytes were assessed per protocol; care was taken to examine oocytes harvested from two separate frogs in the performance of concentration-response studies.
Subtype-selective antagonism protocols
After stable 5-H-ev 5-HT-evoked currents were recorded in an oocyte, varying concentrations of each of the four PEAs examined (10
À11
-10 À4 M) were coapplied together with the test concentration of 5-HT (100 or 10 nM for 5-HT 2A or 5-HT 2C receptors, respectively) for 10 s, to determine whether the different PEAs antagonized the 5-HT induced currents. In all protocols, recovery of the 5-HT-evoked current was mandatory prior to evaluating the effect of an increased concentration of each PEA examined. Recovery was assessed by continual 10-s pulse application of the test concentration of 5-HT until a response in excess of 85% of the initial 5-HTevoked current was attained. Parallel protocols were performed in oocytes injected with 5-HT 2A and 5-HT 2C receptors.
Characterization of the nature of the PEA-induced antagonism of the 5-HT 2A receptor
Several protocols were designed to detail the mechanism of the 5-HT 2A receptor blockade induced by the four PEAs examined. Sets of parallel experiments were performed in oocytes expressing the 5-HT 2A receptor subtype.
Onset of the PEA-induced blockade To assess the experimental condition of the PEA application required to demonstrate the blockade of the 5-HT 2A receptor, two sets of protocols were conducted. In the first series of experiments, 1-1000 nM PEA was coapplied together with the test concentration of 5-HT. In another set of protocols, the PEAs were preapplied for 20, 60, 120 or 180-s of either 3 nM (2C-I) or 10 nM (2C-B or 2C-D) prior to the coapplication of test 5-HT concentration. The current generated by the test concentration of 5-HT was set as 100% response; the responses recorded in the presence of the PEAs were normalized against this standard. Separate sets of oocytes, harvested from two frogs, were used for each of these determinations. A minimum of four separate oocytes were used for each of these protocols.
Displacement of the 5-HT concentration-response curves by the PEAs; rank order of antagonist potency In an additional set of experiments, we assessed how PEA applications shifted the 5-HT concentration-response curves. Complete 5-HT concentration-response curves were obtained for single oocytes prior to and following either the coapplication of PEAs with varying concentrations of 5-HT or 2 min after preincubation with each PEA plus a 10-s coapplication of 5-HT plus the PEA. These entire tests were performed in a single oocyte. Results are graphed as 5-HT concentration-response 
Data quantification and statistical analysis of results
Results are presented as average 7s.e.m. corresponding to experiments performed with four to eight oocytes from at least two separate batches of cells. Based on standard deviation values, parallel experiments revealed that intergroup variability was larger than intra-assay variability for the 5-HT 2 receptors.
The 5-HT-generated currents were plotted against the PEA concentrations using Graph-Pad Software (Graph-Pad Inc., San Diego, CA, U.S.A.) to obtain the median effective agonist concentration (EC 50 ) or, in the case of the antagonists, their median inhibitory concentration (IC 50 and its Àlog, pIC50 s). Nonparametric analysis, Kruskal-Wallis, Mann-Whitney and Friedman & Quade tests were also used for statistical analysis. In all cases, significance was set at a P-value o0.05.
Drugs and chemicals used
The PEAs 2C-I, 2C-B, 2C-D and 2C-H (structures are schematized in Figure 1 ) were synthesized as reported by Shulgin & Shulgin (1991) and prepared as hydrochloride salts (with the exception of 2C-B, which was prepared as the hydrobromide salt). These compounds were dissolved in Barth's solution. 5-HT was purchased from RBI (Natick, MA, U.S.A.). The chemicals used to prepare Barth's buffer solution were of analytical grade and were purchased from Merck (Darmstadt, Germany) or Sigma Chemicals (St Louis, MO, U.S.A.).
Results

5-HT 2A receptor antagonism by 2C-I
This PEA behaves as a partial agonist with an intrinsic efficacy, relative to 5-HT, of about 15% at 5-HT 2A receptors; 100 nM 2C-I elicited a small current (see tracing in Figure 2a ), a result consonant with Acun˜a-Castillo et al. (2002) . However, the coapplication of 1 nM 2C-I plus 100 nM 5-HT reduced the current elicited by 5-HT at the 5-HT 2A receptor. Increasing concentrations of 2C-I abolished the magnitude of the 5-HTevoked currents (Figure 2a,b) . The antagonism was reversible; the rate of recovery depended on the drug concentration, and higher concentrations resulted in the slowest recoveries; complete recovery was attained at highest 2C-I concentrations after a 45-min washout. The antagonism was time-dependent since a 2-min 2C-I preincubation caused more than a 100-fold increase in the antagonist potency compared with 2C-I coapplications (Figure 2,b) . In contrast to the activity of this PEA at the 5-HT 2A receptor, 2C-I averaged 35% of intrinsic activity at the 5-HT 2C receptor and did not alter significantly the currents evoked by 5-HT (see tracings in Figure 2c ) on this receptor, revealing 5-HT 2 receptor subtype selectivity.
Consistent with the apparent selectivity of PEAs for the 5-HT 2A receptor, within the 5-HT 2 receptor family, 3 nM 2C-I did not modify the 5-HT concentration-response curve at the 5-5-HT 2C receptor, even after 2 min of 2-CI application ( Figure  3a,b) . Qualitative similar results were also obtained when 30-100 nM 2C-I was co-applied with 5-HT (data not shown). The finding that the preincubation of 3 nM 2C-I for 60-180 s significantly augmented the magnitude of the 5-HT 2A receptor blockade, as compared to the coapplication protocol, shows that the maximum inhibition is reached in about 3 min (Figure 4b ).
5-HT 2A receptor antagonism by 2C-B
The replacement of the iodine atom by a bromine (2C-B) also resulted in a 5-HT 2A receptor antagonist, with reversible and time-dependent properties much like those described for 2C-I. The potency of 2C-B as a 5-HT 2A antagonist is about 30-fold lower than that of 2C-I (Table 2 ). Similar to 2C-I, a 2-min preapplication of 10 nM 2C-B elicited a downward displacement of the 5-HT concentration-response curve at the 5-HT 2A receptor (maximal current reached 22%) but not at the 5-HT 2C receptor (Figure 3c,d and 5a ). The time dependence of the antagonism is similar to that described for 2C-I (Figure 4b ). The reversibility of the antagonism is illustrated in a representative tracing shown in Figure 4a .
2C-D and 2C-H are also selective 5-HT 2A receptor antagonists
Replacement of the halogen atom at C(4) by a methyl group or a H atom also resulted in compounds that reversibly antagonized the 5-HT-evoked currents at the 5-HT 2A receptor in a concentration-and time-dependent manner. A 2-min application of 10 or 30 nM 2C-D shifted to the right and downwards the 5-HT concentration-response curves at the 5-HT 2A receptor, reducing the maximal 5-HT response to 61.3711.3 and 40.6713.4%, respectively (Figure 5b ). These PEAs did not modify the current evoked by 5-HT at the 5-HT 2C receptor (data not shown). As in the case of the other PEAs, the blockade was reversible and required a 2-min preincubation to attain full blockade. The time course of the blockade was essentially indistinguishable from that of the halogen-substituted PEAs (Figure 4b ).
Relative 5-HT 2A receptor antagonist potency
Increasing the concentration of the PEAs reduced proportionally the magnitude of a challenge 5-HT-evoked current at the 
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Phenylethylamines 5HT 2A antagonist 1169 5-HT 2A receptor. 2C-I was the most potent while 2C-H was the least active; the PEA concentration-response curves were parallel ( Figure 6 ).
Discussion
The present results demonstrate that in X. laevis oocytes, 2C-B, and a series of C(4)-substituted analogs, are 5-HT 2A receptor antagonists; they appear to be selective within the 5-HT 2 receptor family since no inhibition of the 5-HT-evoked currents was detected at the 5-HT 2C receptor. We are fully aware that the present data do not allow us to deduce the nature of the psychostimulant mechanisms of these PEAs; however, the present results demonstrate novel pharmacological properties that might be of interest in the understanding of their psychostimulant properties. Parallel behavioral studies are required to complement the present investigation. Considering that 2C-B, 2C-I and 2C-D are recognized to be hallucinogenic in humans (Shulgin & Shulgin, 1991) , the present results cast doubts on the generally accepted notion that the phenylalkylamine hallucinogens act only as full or partial 5-HT 2A agonists.
There is much evidence that links hallucinogenic drug activity with their affinity at 5-HT 2A receptors, or with their efficacy to alter membrane inositide turnover Nichols et al., 1994; Chambers et al., 2001) . This notion appears well accepted and taken as a 'dogma' to understand the effects of psychotropic drugs, and predicts that most hallucinogenic compounds act mainly as full or partial 5-HT 2A agonists. Notwithstanding, there is a growing body of evidence that does not support this assumption. Pierce & Peroutka (1990) described that D-lysergic acid diethylamide (LSD), a prototypical indoleamine hallucinogenic, acts as a potent 5-HT 2 antagonist. Recently, Rabin et al. (2002) , showed that in PC12 cells expressing the 5-HT 2A receptor both hallucinogenic and nonhallucinogenic drugs, belonging to the indoleamine or phenylethylamine families, stimulate phosphoinositide hydrolysis, one of the intracellular signaling messengers characteristic of the 5-HT 2 family of receptors. Comparison of these results with previous drug discrimination studies suggests an apparent lack of correlation between in vivo hallucinogenic drug action and efficacy in stimulating phosphoinositide hydrolysis. The involvement of phospholipase A 2 has not been definitively excluded (Rabin et al., 2002) . Altogether, the latter 
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Phenylethylamines 5HT 2A antagonist findings may be interpreted as evidence against the notion that 5-HT 2A activation is the sole critical receptor and signaling mechanism involved in the stimulus effects of hallucinogens. Only within the past decade, fairly bulky ligands such as compounds RS 102221, SB 242084, MDL 100907 and 4F 4PP can discriminate among 5-HT 2 receptor subtypes (Herndon et al., 1992; Sorensen et al., 1993; Kennett et al., 1997; Bonhaus et al, 1997; Acun˜a-Castillo et al., 2002) , and have become useful tools to explore the physiology of the 5-HT 2 receptors in vivo and in vitro. Inasmuch as we are aware, this is the first report of a series of compounds that antagonize the 5-HT 2A receptor and which appear to be selective within the 5-HT 2 receptor subtypes.
Although we recognize that the limited number of PEAs examined precludes a confirmatory conclusion, a parsimonious interpretation, based on the relative rank order of potencies of PEAs as antagonist at the 5-HT 2A receptor, strongly suggests that this receptor may have a hydrophobic pocket to accommodate a C(4) substituent, leading to distinct receptor antagonism affinity. We propose that iodine fits optimally into this hypothetical pocket, resulting in the most potent antagonist. Based on the present findings, we suggest that the 5-HT 2C receptor, which bears evident structural similarities with the 5-HT 2A receptor, may not have a similar pocket or the site may be more hydrophilic, since 2C-I, 2C-B and 2C-D, which have hydrophobic C(4) substituents, do not possess an antagonist profile in its interaction at this receptor. In contrast, the putative antagonist site on the 5-HT 2C receptor may accommodate a hydrophilic and possibly hydrated nitro group that leads to antagonism as described by Acun˜a-Castillo et al. (2002) . The lack of PEA antagonism at the 5-HT 2C receptor might also be related to their greater intrinsic activity in this receptor, which in the case of 2C-I averaged 35%, a condition favoring partial agonism rather than 5-HT 2C receptor antagonism.
In addition to the hypothesis that the PEAs fit into a pocket proper of the 5-HT 2A receptor, which might help account for their exclusive 5-HT 2A receptor antagonism, we have not overlooked alternative explanations to explain the PEAs' behavior. One possibility refers to functional receptor coupling selectivity, also known as differential engagement of G proteins, which may influence the interpretation of the present results (see Kurrash-Orbaugh et al., 2003) , pointing out that G proteins may couple within the same cell to various effectors. A substantial spare receptor reserve could also hinder the real-time kinetics of the receptor transduction mechanism. Additionally, the present results and the experimental protocol used cannot discard that PEAs interact with (Blank et al., 1996; Arvanov et al., 1999) or metabotropic glutamate receptors (Gewirtz and Marek, 2000) . It is also well known that PEAs and related compounds facilitate the release of dopamine (Benloucif et al., 1993) , a preponderant transmitter involved in the brain circuitry related to psychostimulant drug responses and their addictive mechanisms. In addition, although we did not address experimentally the putative interaction of PEAs with dopaminergic receptors, it is entirely possible that these receptors are also targets of their action. At present, we cannot fully discard that 5-HT 2C receptor itself may play a role in the psychostimulant action of the PEAs, since most of these compounds are partial agonists at this receptor. The 5-HT 2B receptor has not been established relevant to psychostimulation; furthermore, its expression is restricted to brain sites not linked to the action of these compounds (Kursar et al., 1994; Pompeiano et al., 1994; Bonhaus et al., 1995) . Although some phenylisopropylamine derivatives, structurally related to the PEAs, have 30-40 times lower affinity at 5-HT 2B than at 5-HT 2A receptors (Nelson et al., 1999) , we cannot exclude their participation in the hallucinogenic response of the PEAs. However, based on the classical psychopharmacological association of the PIAs with 5-HT 2A/2C receptors (Fiorella et al., 1995) and their lower affinity at the 5-HT 2B receptor, we favor the action of the PEAs at the other 5-HT 2 receptor subtypes. We consistently observed that the PEAs require at least 2-min equilibrium to attain the maximal inhibition. Several In each curve, the data derived for the 60, 120 or 180-s preapplication were significantly different from that attained by the coapplication of each PEA plus 100 nM 5-HT (Po0.05, the asterisks were avoided for the sake of clarity). The four 4-substituted PEAs antagonized with varying potencies the 100 nM 5-HT-evoked currents in oocytes microinjected with the 5-HT 2A receptor. In these protocols, the PEAs were preapplied for 2 min prior to challenge with 100 nM 5-HT. The IC 50 of each PEA was interpolated from these curves, and is listed in Table 2 as the pIC 50 (Àlog of the IC 50 ). Symbols represent the mean values, and bars the SEM. four to six oocytes from two batches of oocytes were analyzed per curve.
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Phenylethylamines 5HT 2A antagonist possible explanations may be adduced to explain this finding, which is likely not related to the rate of drug diffusion considering the relative low molecular weight of these drugs, and the fact that 5-HT evoked within 10 s its electrophysiological response. We may assume that the kinetics of formation of the PEA-receptor complex is slow because either the rate of receptor association or the rate of their access to the binding site is slower than for 5-HT in their access from extracellular space. With regard to their rather slow on-rate of action, we are aware that bulky C(4) substituents may slow the rates of on and off binding, accounting for the slow onset of the blockade described for these PEAs. However, the present data report that even a hydrogen at C(4) has a slow onset of antagonism and acts as an antagonist, albeit of low potency. Therefore, we must consider the molecule as a whole rather than looking exclusively at the role of the C(4) substituent on the action of this series of compounds. In this regard, Nelson (1991) discussed the influence of bulky lipophilic substituents as determinants of on and off rates of agonist-antagonist binding. The present technique does not allow us to derive firm conclusions except to describe this common property.
Based on the present findings, we foresee that one of the PIA enantiomers, the one with less intrinsic activity, may mimic the action of its corresponding PEA, and therefore behave as a 5-HT 2A receptor antagonist. Using X. laevis oocytes transfected with 5-HT 2 receptors, we observed that (R)-DOI is a full 5-HT 2C receptor agonist that behaves as a partial 5-HT 2A receptor agonist. In contrast, (S)-DOI has negligible efficacy at the 5-HT 2A receptor. Consistent with the present findings, (S)-DOI reduces 5-HT or even (R)-DOI-evoked currents, evidencing an antagonistic profile at the 5-HT 2C receptor (Villalobos et al., unpublished 
observations).
The present findings highlight the subtle pharmacological differences in the interaction of ligands acting differentially at the 5-HT 2A and 5-HT 2C receptors, and the intricacies of drug action as evidenced by their remarkable selectivity of action. The profile of 2C-B and related PEAs as 5-HT 2A antagonists might be considered a turning point in the future development of competitive more potent and selective 5-HT 2A receptor antagonists. It is our hope that these compounds will allow a more comprehensive understanding of the physiology of the 5-HT 2 receptors and their involvement in psychotropic and hallucinogenic responses.
In summary, PEAs such as 2C-B and congeners behaved as potent and reversible 5-HT 2A receptor antagonists in X. laevis oocytes; they appear to be selective within the 5-HT 2 receptor family. Based on the present work, we raise the working hypothesis that the psychostimulant effect of 2C-B and related PEAs might not necessarily the linked to 5-HT 2A receptor activation, but like LSD, might act through other mechanism(s) or other receptors than the 5-HT 2A subtype. The present results maintain open the controversy about 5-HT 2 receptors and the mechanisms of hallucinogenesis. Further pharmacological, behavioral and molecular evidences must be sought for a full understanding of the mechanism(s) of their psychostimulant properties.
